Spironolactone on COVID-19 patients. : To evaluate the efficacy of combination of Dexamethasone and Spironolactone on the time to clinical recovery and freedom from supplemental oxygen dependence in COVID-19 patients.

Medienart:

Klinische Studie

Erscheinungsjahr:

2021

Erschienen:

2021

Enthalten in:

WHO International Clinical Trials Registry Platform - (2021) vom: 24. Nov. Zur Gesamtaufnahme - year:2021

Sprache:

Englisch

Links:

Volltext [kostenfrei]

Themen:

610
Medical Condition: Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhere
Recruitment Status: Not yet recruiting
Study Type: Interventional

Anmerkungen:

WHO International Clinical Trials Registry Platform (https://www.who.int/ictrp/en/), First posted: 04-03-2021, Last updated: 2022-11-24

ICTRP ID:

CTRI/2021/03/031721
NIL

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

WHO007562020